Lymphocytes stimulate expression of 5-lipoxygenase and its activating protein in monocytes in vitro via granulocyte macrophage colony-stimulating factor and interleukin 3

Journal of Clinical Investigation

Volumn 97, Issue 5, 1996, Pages 1293-1301

  Ring, William L ^a   Riddick, Carl A ^a   Baker, Joseph R ^a   Munafo, Dominic A ^a   Bigby, Timothy D ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

arachidonic acid; cytokines; inflammation; leukotriene; macrophages

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; LEUKOTRIENE;

ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; MACROPHAGE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0029926214     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118545     Document Type: Article

References (50)

1. Lewis, R.A., K.F. Austen, and R.J. Soberman. 1990. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N. Engl. J Med. 323:645-655
2. Pueringer, R J., C.C. Bahns, and G.W. Hunninghake. 1992. Alveolar macrophages have greater amounts of the enzyme 5-lipoxygenase than do monocytes. J. Appl. Physiol. 73:781-786.
3. Woods, J.W , J.F. Evans, D. Ethier, S. Scott, P.J Vickers, L. Hearn, J.A. Heibein, S Charleson, and I I, Singer. 1993. 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. J. Exp. Med. 178:1935-1946.
4. 2 to the nuclear fraction upon macrophage activation. Biochem Biophys. Res. Commun. 196:147-153.
5. Samuelsson, B. 1987. Leukotrienes and lipoxins: structure, biosynthesis, and biological effects. Science (Wash. DC). 237:1171-1175.
6. Bigby, T D , and M J Holtzman 1987. Enhanced 5-lipoxygenase activity in lung macrophages compared to monocytes from normal subjects. J. Immunol. 138:1546-1550.
7. Coffey, M.J., S.E. Wilcoxen, and M. Peters-Golden. 1994. Increases in 5-lipoxygenase activating protein expression account for enhanced capacity for 5-lipoxygenase metabolism that accompanies differentiation of peripheral blood monocytes into alveolar macrophages Am. J Respir. Cell Mol. Biol. 11: 153-158.
8. Ring, W.L., C.A Riddick, J R. Baker, D.A. Munafo, and T.D. Bigby. 1996. Human monocytes lose 5-lipoxygenase and its activating protein as they differentiate into monocyte-derived macrophages in vitro. Am. J. Physiol. (Cell Physiol.). In press
9. Bennett, C.F., M.Y. Chiang, B.P. Monia, and S.T. Crooke. 1993. Regulation of 5-lipoxygenase and 5-lipoxygenase-activating protein expression in HL-60 cells Biochem. J. 289:33-39.
10. Steinhilber, D., O. Rådmark, and B. Samuelsson. 1993. Transforming growth factor β upregulates 5-lipoxygenase activity during myeloid cell maturation. Proc. Natl. Acad. Sci. USA. 90:5984-5988.
11. Fair, A., and K.A. Pritchard. 1994. Oxidized low density lipoprotein increases U937 cell 5-lipoxygenase activity: induction of 5-lipoxygenase activating protein. Biochem. Biophys. Res. Commun. 201:1014-1020.
12. Meslier, N., A.J. Aldrich, and T.D. Bigby. 1992. Effect of interferon-γ on the 5-lipoxygenase pathway of rat lung macrophages. Am J. Respir. Cell Mol. Biol. 6:93-99.
13. Owen, W.F., M.E. Rothenberg, D.S. Silberstein, J.C. Gasson, R.L Stevens, K.F. Austen, and R.J. Soberman. 1987. Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts. J. Exp. Med. 166:129-141.
14. Rothenberg, M.E., W.F. Owen, D S. Silberstein, J Woods, R.J. Soberman, K.F. Austen, and R.L. Stevens. 1988. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J. Clin Invest 81:1986-1992.
15. Silberstein, D.S., W.F. Owen, J.C. Gasson, J.F. Dipersio, D.W. Golde, J C. Bina, R Soberman, K.F. Austen, and J.R. David. 1986. Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. J. Immunol 137:3290-3294.
16. 2- ionophore A23187. Clin. Exp. Immunol. 70:484-490.
17. Dahmden, C.A., J. Zingg, F.E. Maly, and A.L. de Weck. 1988. Leukotriene production in human neutrophils primed by recombinant human granulocyte-macrophage colony-stimulating factor and stimulated with the complement component C5a and FMLP as second signals. J. Exp. Med. 167:1281-1294.
18. Krump, E., and P. Borgeat. 1994. Kinetics of 5-lipoxygenase activation, arachidonic acid release, and leukotriene synthesis in human neutrophils: effects of granulocyte-macrophage colony-stimulating factor. Biochim. Biophys. Acta. 1213:135-139.
19. Palmantier, R., M.E. Surette, A. Sanchez, P Braquet, and P. Borgeat 1994. Priming for the synthesis of 5-lipoxygenase products in human blood ex vivo by human granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-α. Lab. Invest 70:696-704.
20. Pouliot, M., P.P. McDonald, L. Khamzina, P. Borgeat, and S.R. McColl. 1994. Granulocyte-macrophage colony-stimulating factor enhances 5-lipoxygenase levels in human polymorphonuclear leukocytes J. Immunol. 152:851-858.
21. Pouliot, M., P.P. McDonald, P. Borgeat, and S.R. McColl. 1994. Granulocyte/macrophage colony-stimulating factor stimulates the expression of the 5-lipoxygenase-activating protein (FLAP) in human neutrophils. J. Exp. Med. 179:1225-1232.
22. Stankova, J., M. Rola-Pleszczynski, and C.M. Dubois. 1995. Granulocyte-macrophage colony-stimulating factor increases 5-lipoxygenase gene transcription and protein expression in human neutrophils. Blood. 85:3719-3726.
23. 4. Eur. J Biochem. 196:395-400.
24. Bøyum, A. 1968. Isolation of mononuclear cells and granulocytes from blood. Scand J. Clin Lab Invest. 21(Suppl. 97):77.
25. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
26. Bigby, T.D., and N. Meslier. 1989. Transcellular lipoxygenase metabolism between monocytes and platelets. J. Immunol 143:1948-1954.
27. 4 hydrolase in human bronchalveolar lavage fluid. J. Clin. Invest. 93 1042-1050.
28. Sokal, R.R., and F.J. Rohlf. 1981. Biometry, W.H. Freeman, San Francisco, CA.
29. Hoshiko, S , O. Radmark, and B. Samuelsson. 1990 Characterization of the human 5-lipoxygenase gene promoter Proc Natl Acad. Sci. USA. 87:9073-9077.
30. Kennedy, B.P., R.E. Diehl, Y. Boie, M. Adam, and R.A Dixon. 1991. Gene characterization and promoter analysis of the human 5-lipoxygenase-activating protein (FLAP). J. Biol Chem 266:8511-8516.
31. Samuelsson, B., S. Hoshiko, and O. Radmark. 1991. Characterization of the promoter of the human 5-lipoxygenase gene. Adv. Prostaglandin Thromboxane Leukotriene Res 21:1-8
32. Schatz-Munding, M , and V. Ullrich. 1992. Priming of human polymorphonuclear leukocytes with granulocyte-macrophage colony-stimulation factor involves protein kinase C rather than enhanced calcium mobilisation. Eur. J. Biochem. 204:705-712.
33. Surette, M.E , R. Palmantier, J. Gosselin, and P. Borgeat. 1993. Lipopolysaccharides prime whole human blood and isolated neutrophils for the increased synthesis of 5-lipoxygenase products by enhancing arachidonic acid availability: involvement of the CD14 antigen. J. Exp. Med. 178:1347-1355.
34. McDonald, P P., M. Pouliot, P. Borgeat, and S.R. McColl. 1993. Induction by chemokines of lipid mediator synthesis in granulocyte-macrophage colony-stimulating factor-treated human neutrophils. J Immunol. 151:6399-6409.
35. Piechele, G , S. Colli, E Tremoli, and A. Maggi. 1993. 5-Lipoxygenase gene expression in HL60 cells during differentiation with DMSO. Pharmacol. Res. 27:53-60.
36. Elliott, M J., M.A. Vadas, J.M. Eglinton, L.S. Park, L.B To, L.G. Cleland, S.C. Clark, and A.F. Lopez. 1989. Recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor show common biological effects and binding characteristics on human monocytes Blood 74 2349-2359.
37. Elliott, M.J., M.A. Vadas, L.G. Cleland, J.R. Gamble, and A F, Lopez. 1990. IL-3 and granulocyte-macrophage colony-stimulation factor stimulate two distinct phases of adhesion in human monocytes. J. Immunol. 145:167-176.
38. Robin, G., S. Markovich, A. Athamna, and Y Keisari. 1991. Human recombinant granulocyte-macrophage colony-stimulating factor augments viability and cytotoxic activities of human monocyte-derived macrophage in long-term cultures. Lymphokine Cytokine Res 10 257-263
39. Nissimov, R.D.L., and Y. Keisari. 1994 Effect of human recombinant granulocyte-macrophage colony-stimulating factor and IL-3 on the expression of surface markers of human monocyte-derived macrophages in long-term cultures. Lymphokine Cytokine Res. 13:239-245.
40. Miyajima, A., A L F Mui, T Ogorochi, and K. Sakamaki. 1993. Receptors for granulocyte-macrophage colony-stimulation factor, interleukin-3, and interleukin-5. Blood 82 1960-1974
41. Lopez, A F , M.J Elliott, J Woodcock, and M.A Vadas. 1992. GM-CSF, IL-3 and IL-5: cross-competition on human haemopoietic cells. Immunol. Today. 13:495-500.
42. Lawrence, D A. 1991. Identification and activation of latent transforming growth factor β. Methods Enzymol. 198:327-336.
43. Vitetta, E.S., R. Fernandez-Botran, C D. Myers, and V.M. Sanders. 1989. Cellular interactions in the humoral immune response. Adv. Immunol. 45: 1-105.
44. Shannon, M F , S R. Himes, and L.S. Coles. 1995. GM-CSF and IL-2 share common control mechanisms in response to costimulatory signals in T cells. J Leukocyte Biol 57:767-773.
45. Bonifati, C., M. Carducci, P. Cordiali Fie, E. Trento, G. Sacerdoti, M. Fazio, and F. Ameglio. 1994. Correlated increases of tumour necrosis factor-α, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients - relationship with disease severity. Clin Exp. Derm 19:383-387
46. Broide, D.H., M. Lotz, A.J. Cuomo, D.A. Coburn, E.C. Federman, and S.I. Wasserman. 1992. Cytokines in symptomatic asthma airways. J. Allergy Clin. Immunol. 89:958-967.
47. Marini, M., E. Avoni, J. Hollemborg, and S. Mattoli. 1992. Cytokine mRNA profile and cell activation in bronchoalveolar lavage fluid from non-atopic patients with symptomatic asthma. Chest. 102:661-669.
48. Kay, A B., S. Ying, V. Verney, M Gaga, S.R. Durhan, R Moqbel, A.J. Wardlaw, and Q. Hamid. 1991. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J. Exp. Med 173:775-778.
49. Masseyn W., B. Friedman, M. Kato, P. Cooper, A. Kagey-Sobotka, L.M. Lichtenstein, and R.P. Schleimer. 1993 Appearance of granulocyte-macrophage colony-stimulating factor activity at allergen-challenged cutaneous late-phase reaction sites. J. Immunol. 150:1084-1092.
50. Walker, C., W. Bauer, R.K. Braun, G. Menz, P. Braun, F. Schwarz, T.T. Hansel, and B. Villiger. 1994. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with cosinophilia. Am. J Respir. Crit. Care Med 150:1038-1048.